CURE Genitourinary Cancers Issue

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.

Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.

A powerful new ally is emerging in cancer care: artificial intelligence.